文献速递慢性肾脏病肾血管病与高血压

基于肌酐与胱抑素C估算的eGFR个体内差异与心力衰竭发病的关联

Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
PubMed 文献 · Am J Kidney Dis · 2022-07-09

在4512例无心力衰竭的慢性肾脏病(CKD)患者中,前瞻性队列研究发现基线及随时间更新的eGFRcys与eGFRcr差值(eGFRdiff)与心力衰竭住院风险相关;eGFRdiff每降低15 mL/min/1.73 m²,风险升高(HR 1.20)。eGFRdiff持续低于-15 mL/min/1.73 m²者风险更高(HR 1.99),而eGFRdiff≥15 mL/min/1.73 m²者风险更低(HR 0.67)。

要点

  • 约三分之一CKD患者eGFRcys与eGFRcr差值超过15 mL/min/1.73 m²。
  • 基线eGFRdiff每降低15 mL/min/1.73 m²,心衰住院风险升高(HR 1.20)。
  • eGFRcys相对eGFRcr下降更快者,心衰住院风险升高(HR 1.49)。

核心结论

  • 在eGFRcys与eGFRcr差异较大的CKD患者中,心力衰竭发病风险与eGFRcys的关联更强。
  • eGFRcys与eGFRcr随时间变化斜率分离也与心力衰竭发病风险独立相关。

研究设计与样本

  • 前瞻性队列研究,纳入慢性肾功能不全队列(CRIC)研究中4512例无心力衰竭的CKD成人。

主要发现

  • 4512例参与者中约三分之一eGFRcys与eGFRcr差值超过15 mL/min/1.73 m²。
  • 多变量调整模型中,基线eGFRdiff每降低15 mL/min/1.73 m²,心力衰竭住院风险升高(HR 1.20,95% CI 1.07-1.34)。
  • 时间更新分析中,与eGFRcys和eGFRcr相近者相比,eGFRdiff低于-15 mL/min/1.73 m²者心力衰竭住院风险更高(HR 1.99,95% CI 1.39-2.86)。
  • 时间更新分析中,与eGFRcys和eGFRcr相近者相比,eGFRdiff≥15 mL/min/1.73 m²者心力衰竭住院风险更低(HR 0.67,95% CI 0.49-0.91)。
  • 与eGFRcys和eGFRcr平行下降者相比,eGFRcys相对eGFRcr下降更快者心力衰竭发病风险更高(HR 1.49,95% CI 1.19-1.85)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 进入CRIC研究由eGFRcr决定,限制了基线eGFRcr值的范围,但未限制eGFRcys值的范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Lower estimated glomerular filtration rate (eGFR) is associated with heart failure (HF) risk. However, eGFR based on cystatin C (eGFRcys) and creatinine (eGFRcr) may differ substantially within an individual. The clinical implications of these differences for risk of HF among persons with chronic kidney disease (CKD) are unknown. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 4,512 adults with CKD and without prevalent HF who enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study. EXPOSURE: Difference in GFR estimates (eGFRdiff; ie, eGFRcys minus eGFRcr). OUTCOME: Incident HF hospitalization. ANALYTICAL APPROACH: Fine-Gray proportional subhazards regression was used to investigate the associations of baseline, time-updated, and slope of eGFRdiff with incident HF. RESULTS: Of 4,512 participants, one-third had eGFRcys and eGFRcr values that differed by over 15 mL/min/1.73 m2. In multivariable-adjusted models, each 15 mL/min/1.73 m2 lower baseline eGFRdiff was associated with higher risk of incident HF hospitalization (hazard ratio [HR], 1.20 [95% CI, 1.07-1.34]). In time-updated analyses, those with eGFRdiff less than -15 mL/min/1.73 m2 had higher risk of incident HF hospitalization (HR, 1.99 [95% CI, 1.39-2.86]), and those with eGFRdiff ≥15 mL/min/1.73 m2 had lower risk of incident HF hospitalization (HR, 0.67 [95% CI, 0.49-0.91]) compared with participants with similar eGFRcys and eGFRcr. Participants with faster declines in eGFRcys relative to eGFRcr had higher risk of incident HF (HR, 1.49 [95% CI, 1.19-1.85]) compared with those in whom eGFRcys and eGFRcr declined in parallel. LIMITATIONS: Entry into the CRIC Study was determined by eGFRcr, which constrained the range of baseline eGFRcr-but not eGFRcys-values. CONCLUSIONS: Among persons with CKD who have large differences between eGFRcys and eGFRcr, risk for incident HF is more strongly associated with eGFRcys. Diverging slopes between eGFRcys and eGFRcr over time are also independently associated with risk of incident HF.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Chen DC, Shlipak MG, Scherzer R, et al. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure. Am J Kidney Dis. 2022. PMID: 35817274. doi:10.1053/j.ajkd.2022.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。